Impact of Mon2 monocyte‐platelet aggregates on human coronary artery disease

Richard A. Brown; Professor Gregory Lip; Chetan Varma; Eduard Shantsila

doi:10.1111/eci.12911

Abstract

1 min read

Monocyte-platelet aggregates with Mon2 are increased in patients with diffuse CAD and therefore could represent an important contributor to accelerated coronary atherosclerotic progression by a mechanism involving microvascular endothelial dysfunction.

Related publications

Article2022

Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events

Marco Magnoni, Daniele Andreini, Angela Pirillo, Patrizia Uboldi, Roberto Latini, Alberico L. Catapano, Aldo Maggioni, Giuseppe Danilo Norata

Letter2019

Monocyte-platelet cross-talk in peripheral artery disease—how much does the pathogenesis of atherosclerosis depend on anatomical location?

Richard A. Brown, Professor Gregory Lip

Preprint2025

The Anatomy of Coronary Risk: How Artery Geometry Shapes Coronary Artery Disease through Blood Flow Haemodynamics -- Latest Methods, Insights and Clinical Implications

Chaofeng Shen, M. Zhang, Haniyeh Keramati, S. Zhang, Ramtin Gharleghi, Jolanda J. Wentzel, Muhammad Owais Khan, Umberto Morbiducci, Abdul Qayyum, Steven Niederer, Shefali Samant, Yiannis S. Chatzizisis, Diogo Esperança Almeida, Tsung-Ying Tsai, Patrick W. Serruys, Susann Beier

Article2011

Platelet Nitric Oxide Signaling System in Patients with Coronary Artery Disease

Mahdi Garelnabi, In Memory of Vinod Kumar Gupta, V. Mallika, Jayashree Bhattacharjee

Annals of Vascular Diseases

Article1983

Intracoronary Platelet Release in Patients with and without Coronary Artery Disease

Freek W.A. Verheugt, Patrick W. Serruys, Huib van Vliet, A. Spijkers, Philip Hugenholtz

Thrombosis and Haemostasis